Literature DB >> 9777518

The prognostic factors of adult gram-negative bacillary meningitis.

C H Lu1, W N Chang, Y C Chuang, H W Chang.   

Abstract

Seventy-seven patients with Gram-negative bacillary meningitis (GNBM), 57 males and 20 females, aged 17-86 years, were identified at Kaohsiung Chang Gung Memorial Hospital, over an 11-year period. Fifty-four infections were community-acquired, and 23 were nosocomial; 49 were spontaneous and 28 occurred after head surgery or neurosurgery. The organisms most frequently involved were Klebsiella pneumoniae, Pseudomonas aeruginosa, Escherichia coli, and Acinetobacter. Rarer pathogens included Citrobacter species, Serratia marcescens, Enterobacter cloacae, and Proteus mirabilis. All patients who did not receive appropriate antibiotic therapy died. The mortality in those treated with appropriate antibiotics was 28%. Other statistically significant prognostic factors included septic shock, initial level of consciousness, hyperosmolar hyperglycemic nonketotic coma, disseminated intravascular coagulation, high cerebrospinal fluid lactate levels and leucocytosis. In the multiple logistic regression analysis, only appropriate antimicrobial therapy and septic shock were strongly associated with mortality even after adjusting for other potentially confounding factors. Despite the high mortality, management can be improved by early diagnosis, early use of appropriate antibiotics, and correction of underlying and associated medical derangement.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9777518     DOI: 10.1016/s0195-6701(98)90021-4

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  16 in total

1.  High incidence of gram-negative bacillary infection and high mortality in adult patients with bacterial meningitis and nasopharyngeal carcinoma.

Authors:  C R Huang; C H Lu; C C Chien; P Y Lee; W N Chang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-07-15       Impact factor: 3.267

2.  Bacterial meningitis in older adults.

Authors:  Diedre Hofinger; Larry E Davis
Journal:  Curr Treat Options Neurol       Date:  2013-08       Impact factor: 3.598

3.  CT and MR imaging features of pyogenic ventriculitis.

Authors:  M B Fukui; R L Williams; S Mudigonda
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

4.  Salmonella meningitis in an adult with type B viral hepatitis and an incidental schwannoma.

Authors:  Fuad Khalil Al-Aani; Salem Abusalah; Rafid Al-Aqeedi; Abdulsalam Ibrahim
Journal:  BMJ Case Rep       Date:  2009-05-18

5.  Treatment of Bacterial Meningitis.

Authors:  Allan R. Tunkel; W. Michael Scheld
Journal:  Curr Infect Dis Rep       Date:  2002-02       Impact factor: 3.725

6.  [Acute meningitis after transrectal prostate biopsy].

Authors:  F Meisel; C Jacobi; R Kollmar; A Hug; M Schwaninger; S Schwab
Journal:  Urologe A       Date:  2003-12       Impact factor: 0.639

7.  Dynamic changes of matrix metalloproteinase-9 in patients with Klebsiella pneumoniae meningitis.

Authors:  Hung-Chin Tsai; Sheng-Fu Liu; Kuan-Sheng Wu; Yung-Ching Liu; Min-Hon Shi; Eng-Rin Chen; Chuan-Min Yen; Susan Shin-Jung Lee; Yen-Lin Huang; Yao-Shen Chen
Journal:  Inflammation       Date:  2008-08       Impact factor: 4.092

8.  First initial community-acquired meningitis due to extended-spectrum beta-lactamase producing Escherichia coli complicated with multiple aortic mycotic aneurysms.

Authors:  Pierre Weyrich; Nicolas Ettahar; Laurence Legout; Agnes Meybeck; Olivier Leroy; Eric Senneville
Journal:  Ann Clin Microbiol Antimicrob       Date:  2012-02-09       Impact factor: 3.944

9.  Cerebritis: an unusual complication of Klebsiella pneumoniae.

Authors:  Mainak Majumdar; David C Simes; Ramesh D Prabha
Journal:  Indian J Crit Care Med       Date:  2009 Jan-Mar

10.  The spectrum of acute bacterial meningitis in elderly patients.

Authors:  Pere Domingo; Virginia Pomar; Natividad de Benito; Pere Coll
Journal:  BMC Infect Dis       Date:  2013-02-27       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.